Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Epigenomics|September 25, 2013
Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemiaEdurne San Jose-Eneriz, Xabier Agirre, Paula Rodríguez-Otero, et al.Haematologica|January 14, 2017
Is immunotherapy here to stay in multiple myeloma?Paula Rodríguez-Otero, Bruno Paiva, Monika Engelhardt, et al.Journal of Clinical Medicine|November 11, 2020
CAR T-Cells in Multiple Myeloma Are Ready for Prime TimePaula Rodríguez-Otero, Felipe Prósper, Ana Alfonso, et al.Drugs of Today (Barcelona, Spain : 1998)|August 19, 2022
Melphalan flufenamide for relapsed/refractory multiple myelomaOmar Nadeem, Maria-Victoria Mateos, Yvonne A Efebera, et al.Hematology, Transfusion and Cell Therapy|October 15, 2022
CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in BrazilVania Hungria, Ana Alfonso Piérola, Jayr Schmidt Filho, et al.European Journal of Radiology|November 17, 2020
The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CTAlberto Paternain, María José García-Velloso, Juan José Rosales, et al.Expert Opinion on Investigational Drugs|September 14, 2020
Melflufen for relapsed and refractory multiple myelomaAlbert Oriol, Alessandra Larocca, Xavier Leleu, et al.Journal of Neuro-Oncology|October 19, 2010
Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphomaJaime Gállego Pérez-Larraya, José Alberto Palma, María Carmona-Iragui, et al.Best Practice & Research. Clinical Haematology|November 10, 2016
Origin of Waldenstrom's macroglobulinaemiaRamón García-Sanz, Cristina Jiménez, Noemí Puig, et al.Open Forum Infectious Diseases|November 14, 2025
Emerging Risk of Campylobacter spp. Infection Associated With Anti-BCMA and Anti-GPRC5D Bispecific AntibodiesIdoia Bilbao, María Ansón, Sara Villar, et al.Pageof 6